Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT05814627 · COMPLETED
Trial details
- NCT number
- NCT05814627
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-15
- Primary completion
- 2026-07-15
- Enrollment
- 487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.